COMMUNIQUÉS West-GlobeNewswire

Clarus Therapeutics Announces FDA Award of 3-Year Market Exclusivity for Jatenzo®
19/08/2019
JATENZO ® is a first-in-class proprietary softgel oral formulation of testosterone undecanoate for testosterone replacement therapy in certain adult hypogonadal men and the first oral testosterone replacement product of [...]
Yield10 Bioscience Expands Research License with Bayer for Evaluation of a Novel C3004 Yield Trait Gene in Soybean
19/08/2019
WOBURN, Mass., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
Qrons Selects PCG Advisory for Investor Relations and Strategic Communications as it Advances its Product Candidates
19/08/2019
NEW YORK, NY,, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Qrons Inc. (OTCQB: QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions for the treatment of [...]
Update: Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wide License and Co-Development of Its Broad-Spectrum Anti-Cancer Drug, KTH 222
19/08/2019
SAN FRANCISCO, CA, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Oncology Pharma (OTCPK: ONPH) is pleased to announce that it signed a Letter of Intent with Kalos Therapeutics (Phoenix, AZ) for a world-wide [...]
Novo Nordisk A/S – Share repurchase programme
19/08/2019
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 19 August 2019 – On 9 August 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the [...]
Fortress Biotech Announces Appointment of Kevin L. Lorenz, J.D., to Board of Directors
19/08/2019
NEW YORK, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and [...]
Predictive Oncology to Report Second Quarter 2019 Financial Results and Provide Company Update on Monday, August 19, 2019
19/08/2019
Revised time for Conference Call to be held August 19, 2019, at 5:30pm Eastern Time MINNEAPOLIS, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc., (NASDAQ: POAI) (“Predictive Oncology ” or “the Company”) an [...]
OraSure Announces Sale of Cryosurgical Systems Business
19/08/2019
BETHLEHEM, Pa., Aug. 19, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced the sale of its cryosurgical [...]
Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wide Licence and Co-Devlopent of Its Broad-Spectrum Anti-Cancer Drug, KTH 222
19/08/2019
SAN FRANCISCO, CA, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Oncology Pharma ( OTCPK : ONPH) is pleased to announce that it signed a Letter of Intent with Kalos Therapeutics (Phoenix, AZ) for a world-wide [...]
Protech Home Medical Reports Solid Third Quarter Fiscal 2019 Financial Results
19/08/2019
Posts Revenue Growth of 7.1% and Adjusted EBITDA Growth of 7.8% NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED [...]
Kiniksa to Present Rilonacept Final Phase 2 Clinical Data at the American Heart Association Scientific Sessions 2019
19/08/2019
HAMILTON, Bermuda, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic [...]
Alkahest Initiates Phase 2 Clinical and Mechanistic Trial of Postoperative Recovery Following Primary Hip or Knee Arthroplasty
19/08/2019
SAN CARLOS, Calif., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical stage biotechnology company focused on developing transformative therapies to treat age-related diseases, today announced the dosing of [...]
Enlivex Therapeutics Announces Positive Outcome From Safety Committee’s Review Of Six Patients With Severe Sepsis Patients; Enrollment Of Last Study Cohort Approved
19/08/2019
Nes Ziona, Israel, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that the safety review committee of the Company’s ongoing Phase Ib [...]
Auxly Enters Into a 300 Acre Hemp Cultivation and Purchase Agreement for the 2019 Cultivation Season
19/08/2019
VANCOUVER, British Columbia, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") today announced that it has entered into a hemp cultivation and purchase agreement ( [...]
VitalHub and Strata Health Announce Strategic Collaboration To Enhance Health and Social Service Provider System Efficiencies Globally
19/08/2019
TORONTO, Aug. 19, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSXV: VHI) is pleased to announce that it has formalized a partnership with Strata Health, the global leader in intelligent patient transition technology. The [...]
The Joint Corp. Acquired Additional Clinic in the San Diego Market
19/08/2019
- Corporate Owned and Managed Portfolio Increases to 58 - SCOTTSDALE, Ariz., Aug. 19, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, [...]
Fulcrum Therapeutics Announces Initiation of ReDUX4, a Phase 2b Clinical Trial of Losmapimod for FSHD
19/08/2019
CAMBRIDGE, Mass., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases [...]
Animal Health Veteran Johnny D. Powers Joins Zomedica Board of Directors
19/08/2019
ANN ARBOR, Mich., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic and pharmaceutical company, today announced that [...]
Transactions under Novozymes’ stock buyback program
19/08/2019
Please read the full announcement in the attached PDF Attachment 2019_31_Stock_Buybackprogram_EN

Pages